Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : BSG005
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I/ Phase II
Sponsor : Alkem Laboratories | JSS Medical Research Asia Pacific
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 07, 2024
Lead Product(s) : BSG005
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I/ Phase II
Sponsor : Alkem Laboratories | JSS Medical Research Asia Pacific
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : BSG005
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : BSG005 is a potentially disruptive antifungal drug with blockbuster potential based on significant safety and potency advantages over competing antifungals, including Amphotericin B, in more than a decade of laboratory and preclinical studies.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 09, 2022
Lead Product(s) : BSG005
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : BSG005
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Select Pharma Laboratories LTD | GreenLight Clinical | Nucleus Network
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 10, 2021
Lead Product(s) : BSG005
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Select Pharma Laboratories LTD | GreenLight Clinical | Nucleus Network
Deal Size : Inapplicable
Deal Type : Inapplicable